Semaglutide and Cholesterol: What the Evidence Shows
Weight loss often improves lipids, and semaglutide cut cardiovascular events in one trial. The honest picture.
The short answer
Losing weight commonly improves cholesterol and triglyceride numbers, and in the SELECT trial semaglutide reduced major cardiovascular events by about 20% (relative) in adults with established heart disease and obesity who did not have diabetes (Lincoff et al., NEJM 2023; PMID 37952131). That is a meaningful finding for that specific population, not a cholesterol drug claim for everyone.
What this means
Improvements in lipids on a GLP-1 are usually driven by weight loss and better metabolic health. The cardiovascular benefit in SELECT applied to a high-risk group and used the brand medication. Semaglutide is not a substitute for a statin or other prescribed cholesterol treatment.
Ready to start?
$199 Skeptics’ Trial, see if it works for you
One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.
Start the 30-day trialHow this relates to what we offer
We provide physician-supervised compounded semaglutide (not FDA-approved or brand-identical). Dr. Sharma reviews your labs, including lipids, and coordinates with your other care. This is general education, not medical advice.
What you can start today at New Hope Weight Loss
After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.
Frequently asked questions
Does semaglutide lower cholesterol?
Weight loss on semaglutide commonly improves cholesterol and triglycerides. It is not a dedicated cholesterol drug, and improvements are largely driven by weight loss and metabolic health.
Did semaglutide reduce heart risk?
In the SELECT trial (PMID 37952131), semaglutide reduced major cardiovascular events by about 20% (relative) in adults with established heart disease and obesity without diabetes. That applies to that population and used the brand drug.
Can semaglutide replace my statin?
No. It is not a substitute for prescribed cholesterol treatment. Coordinate all of your medications with your physician.
Does compounded semaglutide have the same heart data?
No. The cardiovascular data is for the brand medication. Compounded semaglutide is not FDA-approved or reviewed, so that data cannot be assumed to apply.
Does New Hope check my labs?
Dr. Sharma reviews baseline labs, including lipids, and monitors over time. Compounded medications are not FDA-approved.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.